Online citations, reference lists, and bibliographies.
← Back to Search

Microparticles And Polymers For The Mucosal Delivery Of Vaccines.

O’Hagan
Published 1998 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Because microparticles are taken up across the gastrointestinal tract following oral administration, they may be exploited for the oral delivery of labile compounds. For example, microparticles have been used for the oral delivery of peptide and protein drugs, and have resulted in improvements in bioavailability. In addition, microparticles have also been exploited for the oral delivery of vaccines, inducing potent immune responses and protective immunity. However, the extent of uptake of microparticles across the gut may limit their potential for oral delivery. Therefore, intranasal immunization is an attractive approach for the induction of mucosal immunity. Microparticles have also been used for the delivery of vaccines to the respiratory tract. In addition to the use of small microparticles to target antigens to mucosal lymphoid tissues, polymeric coatings may also be employed simply to protect antigens against degradation during transit in the gut. Hence, oral delivery using polymers is not necessarily dependent on the uptake of the delivery system across the gut. Recent studies have indicated that a number of polymeric delivery systems possess significant potential for the development of mucosally administered vaccines. However, further work is needed in a number of areas, including the stabilization of antigens within the polymeric delivery systems.
This paper references
10.3109/10611869409015903
Microsphere absorption by the nasal mucosa of the rat.
H. O. Alpar (1994)
10.3181/00379727-190-42825
Intestinal Uptake of Fluorescent Microspheres in Young and Aged Mice 1
M. Lefevre (1989)
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
S. Challacombe (1992)
Effect of animal age on the uptake of large particulates across the epithelium of the rat small intestine.
L. Simon (1994)
10.1016/0169-409X(90)90020-S
Intestinal translocation of particulates — implications for drug and antigen delivery
D. O'hagan (1990)
THE INTESTINAL UPTAKE OF PARTICLES AND THE IMPLICATIONS FOR DRUG AND ANTIGEN DELIVERY
O'Hagan Dt (1996)
10.1016/S0169-409X(98)00012-X
Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.
Gupta (1998)
10.1111/j.2042-7158.1995.tb06714.x
The Transfer of Polystyrene Microspheres from the Gastrointestinal Tract to the Circulation after Oral Administration in the Rat
J. Eyles (1995)
10.3109/02652049009021848
Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capability to L929 cells in vitro.
W. Rubas (1990)
10.1159/000233553
IgA antibody produced by local presentation of antigen in orally primed rats.
D. S. Cox (1984)
10.1016/0168-3659(90)90133-E
Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches
J. Eldridge (1990)
10.1016/0264-410X(95)00184-3
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
A. Moore (1995)
10.3109/10611869409015904
Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles.
A. M. Hillery (1994)
10.1016/0264-410X(91)90269-C
Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM).
M. Thapar (1991)
10.1128/IAI.63.8.2880-2885.1995
Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.
J. Tseng (1995)
10.1016/0264-410X(89)90231-4
Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization.
D. O'hagan (1989)
Pharmacokinetic evaluation of indomethacin nanocapsules.
V. Andrieu (1989)
10.1016/0168-3659(94)90006-X
The potential use of poly(methacrylic acid) hydrogels for oral administration of drugs and vaccines to ruminants
T. Bowersock (1994)
Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions.
R. Waldman (1972)
10.1128/IAI.64.2.489-494.1996
Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection.
D. I. Jones (1996)
10.1016/B978-0-12-524730-6.50061-0
56 – Endocrine Regulation of Mucosal Immunity: Effect of Sex Hormones and Cytokines on the Afferent and Efferent Arms of the Immune System in the Female Reproductive Tract
C. Wira (1994)
10.1128/IAI.64.3.974-979.1996
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
A. Di Tommaso (1996)
10.1111/j.1749-6632.1983.tb26868.x
SALIVARY ANTIBODIES AND SYSTEMIC TOLERANCE IN MICE AFTER ORAL IMMUNIZATION WITH BACTERIAL ANTIGENS *
S. Challacombe (1983)
10.1159/000230211
Formation of agglutinating and reaginic antibodies in rabbits following oral administration of soluble and particulate antigens.
O. Strannegård (1969)
10.1046/j.1365-2567.1998.00441.x
Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses
Ugozzoli (1998)
10.1016/0264-410X(95)00196-8
Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system.
D. Rafferty (1996)
The number and distribution of lymphoid follicles in the human large intestine.
J. Langman (1986)
10.1111/j.1365-2559.1986.tb02481.x
Lymphoglandular complexes of the colon: structure and distribution
A. O’Leary (1986)
10.1016/0264-410X(95)00158-W
Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen.
S. Jain (1996)
10.1093/INFDIS/167.1.84
Oral immunization with influenza virus in biodegradable microspheres.
Z. Moldoveanu (1993)
10.1016/0378-5173(95)00046-L
Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization
D. O'hagan (1995)
10.1128/JVI.71.4.2844-2850.1997
Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates.
S. Periwal (1997)
10.1016/0168-3659(93)90169-6
In vivo biocompatibility studies of medisorb® 65/35 D,L-lactide/glycolide copolymer microspheres
Kazuhiro Yamaguchi (1993)
10.1016/0168-3659(95)00155-7
Oral vaccination with alginate microsphere systems
T. Bowersock (1996)
Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake.
J. Pappo (1989)
10.1016/0014-4827(61)90092-1
A study of particulate intestinal absorption and hepatocellular uptake. Use of polystyrene latex particles.
E. Sanders (1961)
10.1016/0034-5288(92)90082-D
Protective effects of an oral microencapsulated Mycoplasma hyopneumoniae vaccine against experimental infection in pigs.
C. Weng (1992)
10.1016/0264-410X(96)00063-1
Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres.
C. Yan (1996)
10.1113/expphysiol.1992.sp003662
Confocal analysis of fluorescent bead uptake by mouse Peyer's patch follicle‐associated M cells
C. Porta (1992)
10.1016/0264-410X(95)00243-T
Oral immunization with a model protein entrapped in microspheres prepared from derivatized alpha-amino acids.
S. Haas (1996)
Local antibody response to poliovaccine in the human female genital tract.
P. Ogra (1973)
10.1099/0022-1317-73-8-2141
Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein.
D. O'hagan (1992)
10.1126/SCIENCE.276.5320.1868
Large porous particles for pulmonary drug delivery.
D. Edwards (1997)
10.1016/0378-5173(92)90162-U
Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat
P. U. Jani (1992)
10.1128/IAI.65.7.2676-2684.1997
Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.
C. Bergquist (1997)
10.1038/386410A0
Biologically erodable microspheres as potential oral drug delivery systems
E. Mathiowitz (1997)
10.1016/0168-3659(96)01331-4
Comparative analysis of oral delivery systems for live rotavirus vaccines
J. Duncan (1996)
10.1128/IAI.39.2.1000-1003.1983
Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.
F. Klipstein (1983)
10.1128/IAI.56.1.278-282.1988
Evidence for the phagocytic transport of intestinal particles in dogs and rats.
C. Wells (1988)
10.1080/15287398009529888
Intestinal barrier to large particulates in mice.
M. Lefevre (1980)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.1016/S0264-410X(96)00159-4
Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.
S. Challacombe (1997)
10.1016/0264-410X(89)90156-4
Microparticles as potentially orally active immunological adjuvants.
D. O'hagan (1989)
The adjuvant action of latex particulate carriers.
S. D. Litwin (1965)
10.3109/08820139209069375
Effectiveness of an oral enteric coated vibrio vaccine for use in salmonid fish.
G. Wong (1992)
10.1046/j.1365-2567.1996.d01-639.x
Novel polymer‐grafted starch microparticles for mucosal delivery of vaccines
P. Heritage (1996)
10.1016/S0264-410X(96)00149-1
Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
Y. Tabata (1996)
10.1016/0378-5173(94)90324-7
Controlled release microparticles for oral immunization
D. O'hagan (1994)
10.1530/JRF.0.0740361
Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract.
M. Parr (1985)
10.1128/IAI.63.4.1195-1200.1995
Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres.
R. Shahin (1995)
10.1016/0168-3659(94)90079-5
Microparticulate absorption from the rat intestine
P. G. Jenkins (1994)
Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
K. Maloy (1994)
Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells.
J. Pappo (1991)
10.1002/JPS.2600751009
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
P. Maincent (1986)
10.1016/0264-410X(90)90047-P
Specific immune response in humans following rectal delivery of live typhoid vaccine.
B. Forrest (1990)
10.1016/0167-5699(92)90158-4
The role of nasopharyngeal lymphoid tissue.
C. Kuper (1992)
10.1016/0264-410X(94)00029-M
Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes.
F. Zhou (1995)
10.1128/IAI.62.1.15-23.1994
Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.
B. Haneberg (1994)
10.1016/0378-5173(94)90003-5
Fate of [14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice
A. Ray (1994)
10.1016/0264-410X(93)90011-L
Biodegradable microparticles for oral immunization.
D. O'hagan (1993)
10.1016/S0264-410X(96)00266-6
Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.
D. I. Jones (1997)
10.1159/000233602
Oral induction of the secretory antibody response by soluble and particulate antigens.
D. S. Cox (1984)
Biodegradable microparticles as oral vaccines.
D. O'hagan (1995)
10.1111/j.2042-7158.1990.tb07058.x
Effect on Cerebral Blood Flow of Orally Administered Indomethacin‐loaded Poly(isobutylcyanoacrylate) and Poly(DL‐lactide) Nanocapsules
N. Ammoury (1990)
10.1016/0168-3659(96)01368-5
Co-polymerised peptide particles II: Oral uptake of a novel co-polymeric nanoparticulate delivery system for peptides
A. M. Hillery (1996)
10.1093/INFDIS/172.3.870
Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue.
C. Khoury (1995)
10.1016/0378-5173(93)90083-R
Aerosolized aqueous suspensions of poly(L-lactic acid) microspheres
L. E. Masinde (1993)
10.1016/S1081-1206(10)63499-0
Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
A. Litwin (1996)
10.1016/0264-410X(93)90313-M
Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system.
D. O'hagan (1993)
10.3109/02652049109021877
Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: (II). Effect of temperature and pH on the stability and release behaviour of microspheres.
S. Lin (1991)
10.1016/0264-410X(94)00008-B
Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
E. Cahill (1995)
10.1016/S0168-3659(96)01600-8
Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon
L. Szentkuti (1997)
10.1128/IAI.65.3.853-857.1997
Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.
K. Allaoui-Attarki (1997)
10.1006/VIRO.1994.1463
Enhancement of rotavirus immunogenicity by microencapsulation.
P. Offit (1994)
10.1126/SCIENCE.8493576
Protection against vaginal SIV transmission with microencapsulated vaccine.
P. Marx (1993)
10.1038/NM1096-1116
Oral immunization with an anti–idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection
J. Whittum-Hudson (1996)
10.1111/j.2042-7158.1997.tb06090.x
Oral Delivery and Fate of Poly(lactic acid) Microsphere‐encapsulated Interferon in Rats
J. Eyles (1997)
10.1002/AJA.1001900103
Ultrastructural and cytoarchitectural features of lymphoreticular organs in the colon and rectum of adult BALB/c mice.
R. L. Owen (1991)
10.1016/0168-3659(95)00059-H
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
A. T. Florence (1995)
10.1002/JPS.2600730110
Simple rapid method for the preparation of enteric-coated microspheres.
I. Maharaj (1984)



This paper is referenced by
10.1586/erv.10.89
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
M. Oyewumi (2010)
10.2174/187221409789104728
Recent Patents on Oral Vaccine Design
S. Mangal (2009)
10.3109/10717544.2010.483254
Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides
E. Mata (2010)
Effect of nanosilver particles on hatchability of rainbow trout (Oncorhynchus mykiss) egg and survival of the produced larvae
M. Soltani (2011)
LDDI 33(10).book(LDDI_A_237673.fm)
V. J. Ahire (2007)
10.1021/acs.molpharmaceut.6b00434
Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size.
Jilei Jia (2017)
10.3109/9781420060744-29
Recent Developments in Nonliving Antigen Delivery Systems
Derek O'hagan (2009)
10.4161/hv.7.0.14569
Effectiveness of engineering the nontypeable Haemophilus influenzae antigen Omp26 as an S-layer fusion in bacterial ghosts as a mucosal vaccine delivery
E. Riedmann (2011)
10.1016/S1386-6532(00)00132-3
Overview of vaccinology with special reference to papillomavirus vaccines.
M. Hilleman (2000)
10.1023/A:1016104910582
Recent Advances in Vaccine Adjuvants
M. Singh (2004)
10.1201/9781420039832.CH8
Recombinant Protein Subunit Vaccines and Delivery Methods
A. Banga (2005)
10.1016/J.VACCINE.2006.01.006
Vaccination of mice against intestinal Trichinella spiralis infections by oral administration of antigens microencapsulated in methacrilic acid copolymers.
M. Dea-Ayuela (2006)
10.1007/978-1-4614-0554-2_21
Injectable PLGA Systems for Delivery of Vaccine Antigens
Vesna Milacic (2012)
10.30827/ARS.V48I3.4991
Sistema de administración oral del toxoide tetánico
V. J. Ahire (2007)
10.1016/j.vetimm.2008.07.002
Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus).
Jiyuan Tian (2008)
10.1016/S0928-0987(01)00175-0
Oral vaccination in man using antigens in particles: current status.
D. Brayden (2001)
10.1016/B978-0-323-39981-4.00014-2
Microparticles for Vaccine Delivery
N. Mody (2017)
10.3390/10010065
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
F. Delié (2005)
Developments in Nanoparticle Embedded Biodegradable Polymers for Packaging and Storage of Fruits and Vegetables
R. B. Gautam (2015)
10.3109/02652048.2011.651503
Spray-dried microparticles: a potential vehicle for oral delivery of vaccines
Lipika Chablani (2012)
10.3109/1061186X.2010.529143
Bioadhesive delivery systems for mucosal vaccine delivery
B. Baudner (2010)
Alginate microparticles produced by spray-drying for oral insulin delivery
Kristen Bowey (2009)
10.1016/J.INTIMP.2007.05.003
The immune response and protective efficacy of vaccination with oral microparticle Aeromonas sobria vaccine in mice.
H. Sun (2007)
10.1016/J.VETIMM.2003.08.003
Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections.
V. Snoeck (2003)
10.1128/IAI.72.5.2635-2647.2004
Cross-Reactivity of Schistosoma mansoni Cytosolic Superoxide Dismutase, a Protective Vaccine Candidate, with Host Superoxide Dismutase and Identification of Parasite-Specific B Epitopes
C. Carvalho-Queiroz (2004)
10.5012/JKCS.2003.47.6.601
Surface Mmodification of Poly(DL-lactide-co-glycolide) Nanoparticle
Yu-Mi Oh (2003)
10.1016/B978-012088403-2/50009-5
Microparticles as vaccine delivery systems
D. O'hagan (2006)
Polymerised liposomes as intranasal vaccine adjuvants.
Patel Bp (2004)
10.3109/02652048.2013.788084
Semi-IPN chitosan/polyvinylpyrrolidone microspheres and films: sustained release and property optimisation
Taylan Ozerkan (2013)
10.1007/3-540-45734-8_3
Degradable polymer microspheres for controlled drug delivery
U. Edlund (2002)
10.1517/17425247.4.6.651
Design of nanoparticle-based dry powder pulmonary vaccines
B. Pulliam (2007)
10.1080/02648725.2002.10648027
Engineered Commensal Bacteria as Delivery Systems of Anti-infective Mucosal Protectants
W. Magliani (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar